The wire runs all day · you're seeing 5 of 50 available events
CGEMCullinan Therapeutics Shares Updated CLN-049 Phase 1 Trial Data in Blood Cancers6
IMMXImmix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 20265
COAGHemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition4
IRONDisc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual Meeting3
KURAKura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 20265
LKFTLakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting3